Recursion Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
18.17
|
|
Average Rating
|
3.67
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.38
|
-0.35
|
0.03
|
7.89%
|
|
2022-06-30
|
-0.37
|
-0.38
|
-0.01
|
-2.70%
|
|
2022-03-31
|
0.10
|
-0.33
|
-0.43
|
-430.00%
|
|
2021-12-31
|
-0.31
|
-0.38
|
-0.07
|
-22.58%
|
|
2021-09-30
|
-0.28
|
-0.28
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.23
|
-0.31
|
-0.08
|
-34.78%
|
|
2021-03-31
|
-0.24
|
-1.33
|
-1.09
|
-461.89%
|
|
2020-12-31
|
0.00
|
-0.25
|
-0.25
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.06
|
|
2021-12-31
|
-2.30
|
|
2020-12-31
|
-0.25
|